Nanoparticles of metal–organic cages designed to encapsulate platinum-based anticancer agents†
Abstract
We present a novel design to use metal–organic cages (MOCs) to encapsulate Pt-based anticancer agents for delivery. A fluorescein-conjugated Pt(IV) prodrug of cisplatin is developed for its encapsulation in a cationic MOC via host–guest interactions, which then forms drug-loaded nanoparticles with an anionic polymer.